Related Experiment Video

Updated: Aug 12, 2026

Tissue Triage and Freezing for Models of Skeletal Muscle Disease
05:58

Tissue Triage and Freezing for Models of Skeletal Muscle Disease

Published on: July 15, 2014

Mild hypothermia preserves contractile function and inhibits prostaglandin E2 release from metabolically stressed

V A Cwik1, R Majumdar, M H Brooke

  • 1Division of Neurology, University of Alberta, Edmonton, Canada.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|May 1, 1994
PubMed

Insights

Mild hypothermia protects skeletal muscle from damage by reducing inflammatory mediators like PGE2. Lower temperatures preserved muscle function, though metabolic stress persisted at the lowest tested temperatures.

Area of Science:

  • Muscle physiology
  • Cellular metabolism
  • Hypothermia research

Background:

  • Muscle injury models are crucial for understanding cellular damage.
  • Prostaglandin E2 (PGE2) and lactate are key indicators of muscle metabolic stress and inflammation.
  • Mild hypothermia is explored for its potential cytoprotective effects.

Purpose of the Study:

  • To investigate the protective effects of mild hypothermia on an in vitro model of muscle damage.
  • To assess the impact of varying temperatures on muscle function and biochemical markers.

Main Methods:

  • Dissection of rat epitrochlearis muscles for an in vitro study.
  • Incubation in Krebs-Ringer solution with DNP (a mitochondrial uncoupler).
  • Measurement of PGE2 and lactate release, and contractile response at different temperatures (37, 35, 33, 27°C).

Main Results:

  • At 37°C, DNP induced significant PGE2 and lactate release, with complete loss of contractility.
  • Progressive temperature reduction correlated with preserved contractile force.
  • PGE2 release was completely inhibited at or below 35°C, while high lactate levels persisted at lower temperatures.

Conclusions:

  • Mild hypothermia (≤35°C) demonstrates a protective effect in this in vitro muscle damage model.
  • The inhibition of PGE2 release at lower temperatures suggests a potential mechanism for cytoprotection.
  • Further research may explore hypothermia's role in mitigating muscle injury, potentially analogous to neuroprotection in ischemia.

More Related Videos

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms05:00

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms

Published on: March 3, 2021

Related Concept Videos

Body Temperature01:25

Body Temperature

The body's temperature, measured in degrees, is determined by the balance between heat production and dissipation to the surrounding environment. For instance, if exercising vigorously, the body will produce more heat, causing sweat and dissipating that heat. Despite extreme environmental conditions and physical exertion, the human temperature-control system maintains a constant core body temperature (the temperature of deep tissues, which are the tissues located beneath the skin and other...
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...